Skip to main content
Premium Trial:

Request an Annual Quote

Allscripts Makes $200M Investment in NantHealth

NEW YORK (GenomeWeb) – Allscripts today announced it has acquired a 10 percent stake in informatics firm NantHealth for $200 million in cash.

NantCapital, an investment firm associated with NantHealth founder Patrick Soon-Shiong, has also invested $100 million in Allscripts. The investments follow an alliance between the firms, announced in March 2015, to integrate NantHealth's Genomic Proteomic Sequencing (GPS Cancer) diagnostic test and Eviti treatment protocol planning tool into Allscripts' electronic medical record and practice management software.

The firms said they will jointly develop application programming interfaces (APIs) between their systems as well as integrate NantTransporter, NantCancer Genome Browser, NantContraster, Paradigm, and GPS Cancer sequencing invitations with the Allscripts platform.

NantCapital's investment has been executed through a private placement of Allscripts common stock, the firm said. Allscripts received gross proceeds of approximately $100 million and said the transaction does not change its 2015 guidance.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.